Lanperisone HCl
Lanperisone HCl (NK 433) is a novel orally available centrally acting muscle relaxant with anticancer activity and inhibits mono- and polysynaptic reflex potentials.Lanperisone HCl acts by inducing non-apoptotic cell death in the cell cycle and translational independence.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
321.77
Molecular Formula
C15H19ClF3NO
Notes
Research use only, not for human use.
Receptor
Apoptosis
CAS Number
116287-13-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1336002-01 0.02 mg (E-Coli)
Recombinant Danio rerio WD repeat domain phosphoinositide-interacting protein 4 (wdr45)
Ask
View Details MBS1336002-02 0.02 mg (Yeast)
Recombinant Danio rerio WD repeat domain phosphoinositide-interacting protein 4 (wdr45)
Ask
View Details 
MBS1336002-03 0.1 mg (E-Coli)
Recombinant Danio rerio WD repeat domain phosphoinositide-interacting protein 4 (wdr45)
Ask
View Details MBS1336002-04 0.1 mg (Yeast)
Recombinant Danio rerio WD repeat domain phosphoinositide-interacting protein 4 (wdr45)
Ask
View Details 
MBS1336002-05 0.02 mg (Baculovirus)
Recombinant Danio rerio WD repeat domain phosphoinositide-interacting protein 4 (wdr45)
Ask
View Details MBS1336002-06 0.02 mg (Mammalian-Cell)
Recombinant Danio rerio WD repeat domain phosphoinositide-interacting protein 4 (wdr45)
Ask
View Details